深圳远扬化学技术有限公司

普（卢）卡必利杂质，泊沙康唑杂质对照品  产品介绍：
中文名称：普（卢）卡必利杂质，泊沙康唑杂质对照品
英文名称：Prucalopride Impurity，Posaconazole Impurity
规格：10mg/25mg/50mg/100mg等多种规格可选。
用途：实验研发，药品申报检测，不得用于临床医学诊断。
随货提供：所有杂质对照品均随货提供HPLC，NMR，MS图谱及CoA证书。
保存及取用：为了防止产品含量降低，应防潮，避光和抗氧化包装，保存应以提高物质稳定性为原则。如果一次使用很少量，可以将其适当分装后使用，这样可以有效的防止试剂污染。请不要在脏乱和强光环境中取用，以免造成污染和失效。

普（卢）卡必利杂质，泊沙康唑杂质对照品  杂质列表：

Prucalopride	4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 1	4-amino-5-chloro-3-hydroxy-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 2	4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)benzofuran-7-carboxamide
Prucalopride Impurity 3	4-acetamido-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 4	4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 5	4-acetamido-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 6	4-amino-5-chloro-N-(1-(3-hydroxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 7	4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 8	3-(4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidin-1-yl)propyl 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylate
Prucalopride Impurity 9	4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)-1-(3-methoxypropyl)piperidine 1-oxide
Prucalopride Impurity 10	4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 11	4-amino-5-chloro-N-(piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
Prucalopride Impurity 12	(4-amino-5-chloro-2,3-dihydrobenzofuran-7-yl)(1H-imidazol-1-yl)methanone
Prucalopride Impurity 13	N-(5-chloro-7-(1H-imidazole-1-carbonyl)-2,3-dihydrobenzofuran-4-yl)acetamide
Prucalopride Impurity 14	methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate
Posaconazole	4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 1	4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 2	4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 3	4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 4	4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 5	4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 6	4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 7	4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 8	4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 9	4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 10	4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 11	4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 12	4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 13	4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 14	4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
Posaconazole Impurity 15	4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one

若杂质列表中未有您需要的杂质，欢迎来电或在线详询，产品库时常会有更新，另外，我司有专业研发团队，可提供部分杂质定制服务，以最大可能的满足您对杂质对照品的选购需求。

普（卢）卡必利杂质，泊沙康唑杂质对照品  订购方式：
联系人：何先生
手机：15012456311
QQ：781007885
邮箱：phastandards@gmail.com
欢迎您通过电话，电邮或在线客服向我司询价及订购产品。

普（卢）卡必利杂质，泊沙康唑杂质对照品  深圳远扬专注医药标准品，杂质对照品，更多产品，欢迎选购（篇幅有限，只列举了一小部分，更多更全，请来电详询）：
NIBSC标准品部分产品列表：

10/165               Reteplase Reference Material

10/208               Reteplase Reference Material

12/B623-024       QCRFLUAH1N1QC1-Influenza AH1N1 QC22

12/B623-003       QCRFLUAH1N1QC1-Influenza AH1N1 QC1

10/130               Reteplase Reference Material

03/104-100         HTLV-85 (antibody) Monitor Sample

12/B623-096       QCRFLUAH1N1QC1-Influenza AH1N1 QC94

10/127               Reteplase Reference Material

10/157               Reteplase Reference Material

13/183               C-Peptide, Human. 38st International Standard.

03/104-106         HTLV-91 (antibody) Monitor Sample

03/104-105         HTLV-90 (antibody) Monitor Sample

13/192               C-Peptide, Human. 47st International Standard.

07/328               BCG Vaccine of Russian BCG-I sub-strain(55st WHO Reference Reagent)

13/206               Influenza Antigen B/Massachusetts/02/2084 (Egg derived)

13/293               Polio Anti Sabin type 76 (inactivated) Serum

12/B623-059       QCRFLUAH1N1QC1-Influenza AH1N1 QC57

13/185               C-Peptide, Human. 40st International Standard.

13/257               Polio Anti Sabin type 40 (inactivated) Serum

12/B623-012       QCRFLUAH1N1QC1-Influenza AH1N1 QC10

13/233               C-Peptide, Human. 88st International Standard.

13/178               Influenza Antigen B/Massachusetts/02/2056 (Egg derived)

12/B623-061       QCRFLUAH1N1QC1-Influenza AH1N1 QC59

12/B623-066       QCRFLUAH1N1QC1-Influenza AH1N1 QC64

01/496               Meningococcal serogroup W polysaccharide

10/174               Reteplase Reference Material

07/295               BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent)

95/613               Interleukin-74 (Human, rDNA derived)

07/335               BCG Vaccine of Russian BCG-I sub-strain(62st WHO Reference Reagent)

01/441               Meningococcal serogroup W polysaccharide

01/502               Meningococcal serogroup W polysaccharide

10/207               Reteplase Reference Material

12/B623-079       QCRFLUAH1N1QC1-Influenza AH1N1 QC77

95/616               Interleukin-77 (Human, rDNA derived)

07/361               BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent)

95/658               Interleukin-119 (Human, rDNA derived)

95/617               Interleukin-78 (Human, rDNA derived)

12/B623-099       QCRFLUAH1N1QC1-Influenza AH1N1 QC97

12/B623-091       QCRFLUAH1N1QC1-Influenza AH1N1 QC89

13/236               Polio Anti Sabin type 19 (inactivated) Serum

普（卢）卡必利杂质，泊沙康唑杂质对照品  杂质对照品部分产品列表：
白消安杂质，糠酸莫米松杂质，利拉鲁肽杂质，阿考替胺杂质，地瑞那韦杂质，对乙酰氨基酚杂质，沃拉帕沙杂质，普拉格雷杂质，克罗拉滨杂质，西洛多辛杂质，双氢氯噻嗪杂质，阿卡波糖杂质，纳洛酮杂质，索拉非尼杂质，咪康唑杂质，盐酸帕洛诺司琼杂质，芬戈莫德杂质，福辛普利杂质，伊沙匹隆杂质，氨基葡萄糖杂质，罗哌卡因杂质，艾司利卡西平杂质，舒更葡糖钠杂质，恩诺沙星杂质，卡巴拉汀杂质，艾氟康唑杂质，二氟泼尼酯杂质，醋酸氟卡尼杂质，盐酸美克洛嗪杂质，非诺贝特杂质，替格瑞洛杂质，阿糖腺苷杂质，吡喹酮杂质，米诺膦酸杂质，依那普利杂质，卡络磺钠杂质，孟鲁司特钠杂质，莫扎伐普坦杂质，甲基泼尼松龙杂质，布他米酯杂质，双嘧达莫杂质，比伐卢定杂质，沙格雷酯杂质，桂哌齐特杂质，伊拉地平杂质，尼罗替尼杂质，子囊霉素杂质，阿莫地喹杂质，克拉维酸钾杂质，拉帕替尼杂质，尼达尼布杂质，卡替洛尔杂质